Results 71 to 80 of about 21,501 (259)

A Comprehensive Review of the Genetic Etiology and Management of Orofacial Clefts

Pediatric Discovery, EarlyView.
ABSTRACT Cleft lip (CL) and cleft palate (CP), collectively referred to as orofacial clefts (OFCs), are among the most common birth defects and can have significant effects on speech, nutrition, and physical and psychosocial development. Manifestation, classification, and treatment plans of OFCs are diverse and not standardized.
Emily Kim, Rebeka Dejenie, Caroline Kim, Russell Reid   +3 more
wiley   +1 more source

Fixed Eruptions: Drug, food, and what more?

Clinical Dermatology Review
Fixed drug eruption (FDE) is a common entity encountered in our day-to-day clinical practice. It is a T-cell-dependent pathway with induction of interferon-gamma-producing CD8+ T-cells in the dermis and epidermis.
Prabhakar Mallikarjuna Sangolli, Neethu Mary George   +1 more
doaj   +1 more source

Tranexamic acid-induced fixed drug eruption

Indian Journal of Dermatology, 2015
A 33-year-old male showed multiple pigmented patches on his trunk and extremities after he took tranexamic acid for common cold. He stated that similar eruptions appeared when he was treated with tranexamic acid for influenza 10 months before. Patch test
Natsuko Matsumura, Yuka Hanami, Toshiyuki Yamamoto   +2 more
doaj   +1 more source

Fixed drug eruption

Canadian Medical Association Journal, 2022
Chou, Yu-Ju, Chang, Hua-Ching
openaire   +2 more sources

A general and green approach of pH‐sensitive ZIF‐67 for encapsulating active substances

Smart Molecules, EarlyView.
Zeolitic imidazolate framework‐67 (ZIF‐67) was successfully synthesized in deionized water for 2 h in this work; meanwhile, various active substances could be encapsulated in one‐pot with the same process, resulting in high loading rates. The study delved into the growth mechanism, morphological difference and loading capacity.
Xinyi Sun, Yan Qi, Xinhao Che, Lulu Zhou, Yuxin Li, Lei Zhang, Jing Hu   +6 more
wiley   +1 more source

Antondine Injection-Associated Fixed Drug Eruption: A Case Report

Clinical Medicine Insights: Case Reports
Background: Fixed drug eruption (FDE) is a drug hypersensitivity reaction caused by antibiotics and non-steroidal anti-inflammatory drugs primarily.
Yan Yang, Peng-Fei Li, Qiang Ma, Xiao-Na Wang, Qing Chen, Ling-Yun Ma, Hao Tang, Zhen Wang   +7 more
doaj   +1 more source

Reply to: Superficial Pustular Folliculitis of the Face and Neck—A Non‐Infectious Eruption Responding to Topical Steroids

JEADV Clinical Practice, Volume 5, Issue 2, Page 702-703, June 2026.
Jinfeng Liu, Zhuokun Ran, Suhong Shi, Wei Hua   +3 more
wiley   +1 more source

Media‐Dependent Growth, Stress Responses, and Metal Accumulation Patterns in Azolla imbricata (Roxb.) Nakai Exposed to As, Cd, Cu, Pb, and Zn: Individual and Combination Effects (Synergistic, Antagonistic, and Additive)

Environmental Toxicology, EarlyView.
ABSTRACT In this study, we examined metal accumulation and biochemical responses of Azolla imbricata (Roxb.) Nakai exposed to water medium (WM) and nutrient medium (NM) under single and combined (co‐exposure) treatments with five metals (As, Cd, Cu, Pb, and Zn) at 10% environmentally relevant concentrations.
Sung‐Chul Hong, Je‐Sung Park, Seong‐Ho Jang, Eun‐Sang Jung, Byung‐Gil Jung, Anisa Dea Novianti, Velmurugan Palanivel, Young‐Chae Song, Arpita Kumari, Geetha Parameswaran, Sivakumar Subpiramaniyam   +10 more
wiley   +1 more source

Tapinarof as a Therapeutic Aryl Hydrocarbon Receptor‐Modulating Agent in the Treatment of Atopic Dermatitis

The Journal of Dermatology, Volume 53, Issue 6, Page 867-879, June 2026.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory dermatitis underpinned by Type 2 inflammation driven by cytokines such as IL‐4 and IL‐13. It is characterized by skin barrier dysfunction, Th2 immune deviation, and pruritus. While biologics and oral Janus kinase (JAK) inhibitors demonstrate high therapeutic efficacy by targeting cytokines that ...
Gaku Tsuji, Yoko Fuyuno, Koji Kawamura, Ayako Yumine, Masaki Takemura, Yasutaka Mitamura, Kazuhiko Yamamura, Takeshi Nakahara   +7 more
wiley   +1 more source

Real‐World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study)

The Journal of Dermatology, EarlyView.
ABSTRACT Upadacitinib (UPA) is a selective Janus kinase 1 inhibitor that improves moderate‐to‐severe atopic dermatitis, but real‐world strategies to maintain remission after response remain unclear. We conducted a multicenter retrospective study in Japan of 219 patients aged ≥ 12 years who achieved protocol‐defined remission, defined as Investigator's ...
Yuichiro Tsunemi, Atsuyuki Igarashi, Takeshi Ishido, Hidehisa Saeki   +3 more
wiley   +1 more source